Alkem Labs has acquired Adroit Biomed and Bombay Ortho Industries for around Rs 290 crore to boost its domestic market positioning. These strategic acquisitions will enable Alkem to diversify its ...

Headquartered in Mumbai India Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development manufacture and sale of ...

Alkem Laboratories has announced two strategic acquisitions totaling Rs 287 crores to strengthen its domestic market presence. The company will acquire Adroit Biomed for Rs 140 crore and Bombay Ortho ...

Alkem Laboratories Ltd., incorporated in the year 1973, is a Large Cap company (having a market cap of Rs 61,592.12 Crore) operating in Pharmaceuticals sector. Alkem Laboratories Ltd. key ...

News for Alkem Laboratories Ltd. Alkem Laboratories Q3 Profit Rises 5% to Rs 626 Cr Alkem Laboratories's Q3 net profit increased by 5% to Rs 626 crore, driven by higher sales. The company also ...

Alkem Laboratories has announced two acquisitions – in the dermatology and medical device segments – to strengthen its position in the domestic market. The company has signed a binding term ...

Based on the one-year price targets offered by 17 analysts, the average target price for Alkem Laboratories Ltd (NSE:ALKEM) is $5726.05 with a high estimate of $7225.00 and a low estimate of $4330.00.

Alkem's promoters, with a 56.38% stake worth about Rs 42,280 crore, have hired Nomura as the banker for the stake sale. Reports suggested that Alkem's promoter was aiming to sell 8.5 lakh shares ...

Homegrown drugmaker Alkem Laboratories Ltd has struck separate deals to acquire two smaller peers for a cumulative Rs 287 crore ($32.8 million) in cash, as it looks to expand its product portfolio and ...

For Q3FY25, Alkem reported a 6% year-on-year increase in net profit to ₹641 crore, though profit declined 9% sequentially. (Image: Pixabay) Alkem Laboratories Ltd has announced the acquisition ...